Company · CIK 1593899

# Atea Pharmaceuticals, Inc.

| CIK | [1593899](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001593899) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | MA |
| Business address | MA |
| Listed | AVIR (Nasdaq) |
| First annual or quarterly report | 2020-12-10 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-283073 | Shelf Effective | 2024-11-07 | 2024-11-19 | 2 |
| 333-261344 | Shelf Effective | 2021-11-24 | 2022-05-12 | 2 |
| 333-249404 | IPO Final prospectus | 2020-10-09 | 2020-10-30 | 5 |

## Filings

 10

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2024-11-19 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1593899/999999999524003516/9999999995-24-003516-index.htm) Declared effective | 333-283073 | 9999999995-24-003516 |
| 2024-11-07 | [S-3](https://www.sec.gov/Archives/edgar/data/1593899/000119312524253272/0001193125-24-253272-index.htm) Shelf registered | 333-283073 | 0001193125-24-253272 |
| 2022-05-12 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1593899/999999999522001427/9999999995-22-001427-index.htm) Declared effective | 333-261344 | 9999999995-22-001427 |
| 2021-11-24 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1593899/000119312521340320/0001193125-21-340320-index.htm) Shelf registered | 333-261344 | 0001193125-21-340320 |
| 2020-10-30 | [424B4](https://www.sec.gov/Archives/edgar/data/1593899/000119312520282645/0001193125-20-282645-index.htm) Final prospectus | 333-249404 | 0001193125-20-282645 |
| 2020-10-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1593899/999999999520003030/9999999995-20-003030-index.htm) Declared effective | 333-249404 | 9999999995-20-003030 |
| 2020-10-26 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1593899/000119312520275997/0001193125-20-275997-index.htm) Amendment | 333-249404 | 0001193125-20-275997 |
| 2020-10-23 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1593899/000119312520274635/0001193125-20-274635-index.htm) Amendment | 333-249404 | 0001193125-20-274635 |
| 2020-10-09 | [S-1](https://www.sec.gov/Archives/edgar/data/1593899/000119312520267199/0001193125-20-267199-index.htm) Registration filed | 333-249404 | 0001193125-20-267199 |
| 2020-06-19 | [DRS](https://www.sec.gov/Archives/edgar/data/1593899/000095012320006302/0000950123-20-006302-index.htm) Draft made public | 377-03231 | 0000950123-20-006302 |

[All filings of this company](https://equitycapital.markets/filings?cik=1593899) · [CSV](https://equitycapital.markets/filings.csv?cik=1593899)

---
Source page: https://equitycapital.markets/company/1593899 · Data: U.S. SEC EDGAR · CC BY 4.0